Nivolumab, Relatlimab
Opdualag 80 mg/240 mg, concentraat voor oplossing voor infusie
In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
- OpdualagBrazil · Bristol-Myers Squibb Farmacêutica LtdaSame brand
- OpdualagCanada · 240 MG / 20 ML + 80 MG / 20 ML · Solution · Bristol-Myers Squibb CanadaSame brand
- Opdualag 240 MG/80 MG Concentrado Para Solucion Para PerfusionSpain · 85,20 mg + 255,60 mg · concentrado para solución para perfusión · Bristol-Myers Squibb Pharma EeigSame brand
- OpdualagEuropean Union · Bristol-Myers Squibb Pharma EEIGSame brand
- OpdualagCroatiaSame brand
- OpdualagItaly · Concentrato per soluzione per infusione · Bristol-Myers Squibb Pharma Eeig